Glucocorticoid receptor PROTACs for the treatment of prostate cancer and other malignancies

Authors :: Yonathan Lissanu Deribe
Philip Jones
James T. Link
Source :: Journal of Clinical Oncology. 36:e14545-e14545
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e14545Background: Many proteins are difficult to drug, limiting the approaches to treat malignancy. To address the problem, technologies were invented that are not clinically relevant. Proteolysis ...

Subjects :: Drug
Cancer Research
medicine.diagnostic_test
business.industry
media_common.quotation_subject
Proteolysis
Limiting
Malignancy
medicine.disease
humanities
Prostate cancer
Glucocorticoid receptor
Oncology
Cancer research
medicine
business
media_common

Tools